Content area
Full Text
José Molina. Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, San José, Costa Rica.
Gloriana Barrantes. Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, San José, Costa Rica.
Carlos Quesada-Gómez. Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, San José, Costa Rica.
César Rodríguez. Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, San José, Costa Rica.
Evelyn Rodríguez-Cavallini. Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, San José, Costa Rica.
Address correspondence to: Evelyn Rodríguez-Cavallini, MSc, Laboratorio de Investigación en Bacteriología Anaerobia, Facultad de Microbiología, Centro de Investigación en Enfermedades Tropicales, Universidad de Costa Rica, Ciudad Universitaria Rodrigo Facio, 2060 San José, Costa Rica, E-mail: [email protected]
Introduction
Worldwide, most anaerobic gram-negative bacterial infections are due to species of Bacteroides and closely related genera.33,52 These infections, which may be associated with mortality rates approaching 20%,52 are usually treated with β-lactam drugs (with or without of β-lactamase inhibitors), carbapenems, clindamycin, metronidazol, and newer quinolones.
Due to the growing number of antibiotic-resistant strains of Bacteroides spp. and related species globally,4,40 and considering that these bacteria are characterized by a large diversity of resistance mechanisms and high resistance levels,42 the CLSI recommends monitoring for antibiotic resistance,22 which can vary by geographic zones and even within healthcare facilities within a single region.1,39,52 Monitoring activities should be prioritized in developing countries such as Costa Rica, due to a greater potential for misuse in hospitals, the community, and in extrahospitalary settings such as farmlands and livestock in those regions.10
It is not unusual to find strains of Bacteroides and closely related genera with genes that confer resistance to β-lactams, tetracycline, and clindamycin.52 Moreover, strains with acquired resistance to metronidazole or mutations in gyrases that result in quinolone resistance are beginning to emerge.13,42,52 It is unusual to...